Edition:
United Kingdom

Michael Erman

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

18 Jun 2018

How U.S. tax reform rewards companies that shift profit to tax havens

The corporate tax cut passed by U.S. President Donald Trump and fellow Republicans that was in part designed to help dissuade U.S. companies from moving profits overseas may instead make the practice a lot more rewarding.

06 Jun 2018

U.S. drug prices hit by insurer tactic against copay assistance: analysis

NEW YORK A recently adopted tactic by U.S. health plans to limit the financial assistance drugmakers provide directly to consumers for prescription medicines is taking a toll on drug prices, according to a new analysis released on Tuesday.

30 May 2018

Allergan to sell women's health, infectious disease units

NEW YORK Drugmaker Allergan Plc said on Wednesday it plans to sell two of its smaller businesses, the women's health and infectious disease units, as Chief Executive Brent Saunders works to end a steep slide in its share price over the last year.

30 May 2018

Allergan plans sales of women's health, infectious disease units

NEW YORK Drugmaker Allergan Plc plans to sell off its women's health and infectious disease businesses as Chief Executive Brent Saunders works to end the steep slide in its share price over the last year.

30 May 2018

Allergan plans sales of women's health, infectious disease units

NEW YORK, May 30 Drugmaker Allergan Plc plans to sell off its women's health and infectious disease businesses as Chief Executive Brent Saunders works to end the steep slide in its share price over the last year.

17 May 2018

FDA names drugmakers potentially acting to delay cheap generics

The U.S. Food and Drug Administration on Thursday listed a number of drugmakers it said could be improperly blocking access to their medicines in order to delay generic competition.

14 May 2018

U.S. to consider expanding Medicare drug price negotiation

WASHINGTON/NEW YORK The Trump administration is considering expanding Medicare's ability to negotiate the cost of drugs by giving private payers a role in setting the price of medicines administered in hospitals and doctors' offices, Health and Human Services Secretary Alex Azar said on Monday.

09 May 2018

FDA says Mylan's EpiPen is in shortage in U.S.

U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy treatment. | Video

09 May 2018

FDA says Mylan's EpiPen is in shortage in U.S.

U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy treatment. | Video

09 May 2018

Mylan says U.S. customers may have trouble getting EpiPens

NEW YORK Mylan NV said on Tuesday that U.S. consumers may have difficulty getting EpiPen prescriptions filled after manufacturing problems constrained supply, but the drugmaker did not say there was a shortage of its emergency allergy treatment. | Video

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,682.27 + 125.83 +1.67%
DAX 12,579.72 + 67.81 +0.54%
CAC 40 5,387.38 + 71.37 +1.34%
TR Europe 177.36 + 2.36 +1.35%
GBP/USD 1.3272 +0.03%
GBP/EUR 1.1383 +0.03%
EUR/USD 1.1655 +0.00%
Gold 1,270.20 +3.00 +0.24%
Oil 69.28 +3.74 +5.71%
Corn 357.00 +0.00 +0.00%